ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 183 filers reported holding ANI PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $124,749 | +1511.1% | 1,959 | +1649.1% | 0.00% | – |
Q1 2024 | $7,743 | -96.9% | 112 | -97.5% | 0.00% | -100.0% |
Q4 2023 | $247,689 | +1391.7% | 4,492 | +1470.6% | 0.00% | +200.0% |
Q3 2023 | $16,605 | -24.8% | 286 | -30.2% | 0.00% | 0.0% |
Q2 2023 | $22,070 | +104995.2% | 410 | -20.7% | 0.00% | 0.0% |
Q1 2023 | $21 | +75.0% | 517 | +78.3% | 0.00% | – |
Q4 2022 | $12 | -100.0% | 290 | -89.7% | 0.00% | -100.0% |
Q3 2022 | $91,000 | +600.0% | 2,813 | +540.8% | 0.00% | – |
Q2 2022 | $13,000 | +116.7% | 439 | +108.1% | 0.00% | – |
Q1 2022 | $6,000 | -53.8% | 211 | -26.0% | 0.00% | – |
Q4 2021 | $13,000 | -58.1% | 285 | -69.2% | 0.00% | -100.0% |
Q3 2021 | $31,000 | -46.6% | 924 | -44.2% | 0.00% | -50.0% |
Q2 2021 | $58,000 | +205.3% | 1,655 | +217.7% | 0.00% | – |
Q1 2021 | $19,000 | -38.7% | 521 | -51.2% | 0.00% | -100.0% |
Q4 2020 | $31,000 | -87.4% | 1,068 | -87.8% | 0.00% | -66.7% |
Q3 2020 | $246,000 | +382.4% | 8,733 | +445.5% | 0.00% | +50.0% |
Q2 2020 | $51,000 | +59.4% | 1,601 | +315.8% | 0.00% | 0.0% |
Q2 2019 | $32,000 | +190.9% | 385 | +53.4% | 0.00% | +100.0% |
Q4 2018 | $11,000 | -59.3% | 251 | -50.9% | 0.00% | -50.0% |
Q3 2017 | $27,000 | -10.0% | 511 | -15.7% | 0.00% | -33.3% |
Q1 2017 | $30,000 | +500.0% | 606 | +630.1% | 0.00% | +200.0% |
Q4 2016 | $5,000 | -90.9% | 83 | -89.9% | 0.00% | -80.0% |
Q3 2016 | $55,000 | +323.1% | 822 | +267.0% | 0.01% | +400.0% |
Q2 2016 | $13,000 | -88.0% | 224 | -91.8% | 0.00% | -90.0% |
Q3 2015 | $108,000 | – | 2,738 | – | 0.01% | – |
Q4 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2014 | $183,000 | +185.9% | 5,313 | +158.9% | 0.02% | +200.0% |
Q1 2014 | $64,000 | +3100.0% | 2,052 | +1931.7% | 0.01% | – |
Q4 2013 | $2,000 | +100.0% | 101 | +40.3% | 0.00% | – |
Q3 2013 | $1,000 | – | 72 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |